Harmon Cyrus
Director
SaleAlert
- Shares
- 12,500
- Price
- $11.71
- Value
- $146,425
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•36 filings
OLMA
Olema Pharmaceuticals, Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$24,739,344
6 distinct insiders
Highlighted alerts
29
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get OLMA insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
OLMA overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
84
Raw transactions
Everything returned by the filing
29
Voluntary view
P/S trades after deterministic checks
55
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 650,000
- Price
- $0.00
- Footnotes
- 1
25% of the shares subject to the option vest on August 11, 2027 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Harmon Cyrus
Director
SaleAlert
- Shares
- 12,500
- Price
- $11.58
- Value
- $144,738
Mitchell Shawnte
CHIEF LEGAL OFFICER
SaleAlert
- Shares
- 233
- Price
- $24.69
- Value
- $5,753
Mitchell Shawnte
CHIEF LEGAL OFFICER
SaleAlert
- Shares
- 24,767
- Price
- $24.25
- Value
- $600,600
Mitchell Shawnte
CHIEF LEGAL OFFICER
SaleAlert
- Shares
- 15,000
- Price
- $23.01
- Value
- $345,150
Harmon Cyrus
Director
SaleAlert
- Shares
- 10,000
- Price
- $26.88
- Value
- $268,800
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
SaleAlert
- Shares
- 100,000
- Price
- $28.73
- Value
- $2,873,000
Harmon Cyrus
Director
SaleAlert
- Shares
- 3,489
- Price
- $29.12
- Value
- $101,600
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
SaleAlert
- Shares
- 35,003
- Price
- $28.99
- Value
- $1,014,737
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
SaleAlert
- Shares
- 14,997
- Price
- $28.60
- Value
- $428,914
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
SaleAlert
- Shares
- 200
- Price
- $28.49
- Value
- $5,698
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
SaleAlert
- Shares
- 49,800
- Price
- $27.60
- Value
- $1,374,480
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
SaleAlert
- Shares
- 3,822
- Price
- $28.01
- Value
- $107,054
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
SaleAlert
- Shares
- 10,000
- Price
- $28.34
- Value
- $283,400
Zojwalla Naseem
Chief Medical Officer
SaleAlert
- Shares
- 99,509
- Price
- $27.66
- Value
- $2,752,419
Zojwalla Naseem
Chief Medical Officer
SaleAlert
- Shares
- 100,000
- Price
- $28.04
- Value
- $2,804,000
Harmon Cyrus
Director
SaleAlert
- Shares
- 2,881
- Price
- $28.53
- Value
- $82,195
Zojwalla Naseem
Chief Medical Officer
SaleAlert
- Shares
- 12,921
- Price
- $28.93
- Value
- $373,805
Zojwalla Naseem
Chief Medical Officer
SaleAlert
- Shares
- 57,079
- Price
- $28.03
- Value
- $1,599,924
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
SaleAlert
- Shares
- 6,046
- Price
- $31.39
- Value
- $189,784
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
SaleAlert
- Shares
- 43,729
- Price
- $30.40
- Value
- $1,329,362
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
SaleAlert
- Shares
- 1,225
- Price
- $28.08
- Value
- $34,398
CLARK IAN T
Director
SaleAlert
- Shares
- 41,840
- Price
- $30.48
- Value
- $1,275,283
CLARK IAN T
Director
SaleAlert
- Shares
- 193,056
- Price
- $29.71
- Value
- $5,735,694
CLARK IAN T
Director
SaleAlert
- Shares
- 29,904
- Price
- $28.83
- Value
- $862,132
Harmon Cyrus
Director
SaleAlert
- Shares
- 3,086
- Price
- $8.32
- Value
- $25,676
Harmon Cyrus
Director
SaleAlert
- Shares
- 10,000
- Price
- $8.33
- Value
- $83,300
Harmon Cyrus
Director
SaleAlert
- Shares
- 1,914
- Price
- $8.08
- Value
- $15,465
Harmon Cyrus
Director
SaleAlert
- Shares
- 10,000
- Price
- $8.04
- Value
- $80,400
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jul 24, 2026 | Harmon Cyrus Director | Sale | 12,500 | $11.71 | $146,425 | |
| Jul 23, 2026 | Harmon Cyrus Director | Sale | 12,500 | $11.58 | $144,738 | |
| Mar 04, 2026 | Mitchell Shawnte CHIEF LEGAL OFFICER | Sale | 233 | $24.69 | $5,753 | |
| Mar 04, 2026 | Mitchell Shawnte CHIEF LEGAL OFFICER | Sale | 24,767 | $24.25 | $600,600 | |
| Mar 03, 2026 | Mitchell Shawnte CHIEF LEGAL OFFICER | Sale | 15,000 | $23.01 | $345,150 | |
| Jan 20, 2026 | Harmon Cyrus Director | Sale | 10,000 | $26.88 | $268,800 | |
| Jan 15, 2026 | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | Sale | 100,000 | $28.73 | $2,873,000 | |
| Jan 14, 2026 | Harmon Cyrus Director | Sale | 3,489 | $29.12 | $101,600 | |
| Jan 14, 2026 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | 35,003 | $28.99 | $1,014,737 | |
| Jan 14, 2026 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | 14,997 | $28.60 | $428,914 | |
| Jan 13, 2026 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | 200 | $28.49 | $5,698 | |
| Jan 13, 2026 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | 49,800 | $27.60 | $1,374,480 | |
| Jan 13, 2026 | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | Sale | 3,822 | $28.01 | $107,054 | |
| Jan 12, 2026 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | 10,000 | $28.34 | $283,400 | |
| Dec 23, 2025 | Zojwalla Naseem Chief Medical Officer | Sale | 99,509 | $27.66 | $2,752,419 | |
| Dec 22, 2025 | Zojwalla Naseem Chief Medical Officer | Sale | 100,000 | $28.04 | $2,804,000 | |
| Dec 22, 2025 | Harmon Cyrus Director | Sale | 2,881 | $28.53 | $82,195 | |
| Dec 19, 2025 | Zojwalla Naseem Chief Medical Officer | Sale | 12,921 | $28.93 | $373,805 | |
| Dec 19, 2025 | Zojwalla Naseem Chief Medical Officer | Sale | 57,079 | $28.03 | $1,599,924 | |
| Dec 19, 2025 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | 6,046 | $31.39 | $189,784 | |
| Dec 19, 2025 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | 43,729 | $30.40 | $1,329,362 | |
| Dec 19, 2025 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sale | 1,225 | $28.08 | $34,398 | |
| Dec 19, 2025 | CLARK IAN T Director | Sale | 41,840 | $30.48 | $1,275,283 | |
| Dec 19, 2025 | CLARK IAN T Director | Sale | 193,056 | $29.71 | $5,735,694 | |
| Dec 19, 2025 | CLARK IAN T Director | Sale | 29,904 | $28.83 | $862,132 | |
| Sep 18, 2025 | Harmon Cyrus Director | Sale | 3,086 | $8.32 | $25,676 | |
| Sep 18, 2025 | Harmon Cyrus Director | Sale | 10,000 | $8.33 | $83,300 | |
| Sep 16, 2025 | Harmon Cyrus Director | Sale | 1,914 | $8.08 | $15,465 | |
| Sep 16, 2025 | Harmon Cyrus Director | Sale | 10,000 | $8.04 | $80,400 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.